Clinical Development

Clinical Stage Biotech Domain Database

Access the comprehensive database of clinical stage biotech company domains. From Phase I first-in-human trials to pivotal Phase III studies, discover verified websites of companies actively conducting clinical trials worldwide.

View Pricing Plans Explore Full Database Try Live Demo

The Complete Clinical Biotech Intelligence

Navigate the clinical development landscape with comprehensive data on companies in human trials.

Track Clinical Pipeline Progress

Clinical stage biotechs represent some of the most dynamic investment opportunities in life sciences. Our database provides access to companies across all phases of clinical development, from IND-enabled programs to registration-ready candidates.

Whether you're monitoring trial readouts, tracking competitive positioning, or identifying M&A targets, our database delivers intelligence on companies actively advancing drugs through human clinical trials.

"Clinical stage biotech companies saw record IPO activity, with over $12 billion raised in 2024, reflecting investor appetite for de-risked pipeline assets." We also maintain a comprehensive database of Biologics Developers.

-- Biotech IPO Analysis, 2024

Clinical Stage Database Coverage

Comprehensive coverage of the clinical development sector. Detailed firmographics for Specialty Pharma are also available.

3,800+
Clinical Stage Domains
1,200+
Phase II/III Companies
2,400+
Phase I Companies
Weekly
Updates

Phase I

First-in-human trials

Phase II

Proof-of-concept studies You may also be interested in our Commercial Pharma dataset. See also our curated list of Generic Drug Companies.

Phase III

Pivotal registration trials

NDA/BLA Filed

Regulatory submissions

Multi-Regional

Global clinical programs We also maintain a comprehensive database of Small Molecule Companies.

Pediatric

Pediatric study programs

Access Clinical Stage Intelligence

Get instant access to 3,800+ clinical stage biotech domains with comprehensive enrichment data.

View Pricing Plans Back to Biotech & Biomedical